54 results
424B3
BTTX
Better Therapeutics Inc
28 Dec 23
Prospectus supplement
9:23pm
and marketing efforts;
the initiation, timing, progress, results, safety and efficacy, and cost of our research and development programs and our … in October 2023. We will continue to incur significant research and development and other expenses related to our preclinical and clinical development
8-K
EX-99.1
921pmj5y
9 Nov 23
Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
7:03am
424B5
y21wp3mo7 susol5l5f
9 Aug 23
Prospectus supplement for primary offering
4:37pm
8-K
EX-99.1
pja016
9 Aug 23
Better Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:07pm
424B5
e23r65nehol2e998iyzb
26 Jul 23
Prospectus supplement for primary offering
5:04pm
424B5
4lh5zx3wa
11 May 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-99.1
mzjvp twh40p
11 May 23
Better Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
7:33am
S-3
m6m8 p8i1f
17 Apr 23
Shelf registration
5:48pm